Molecular docking and molecular dynamics simulations were conducted to assess propolis compounds of sulabiroin-A, sulabiroin-B, and broussoflavonol F as tuberculosis (TB) inhibitors with rifampicin as the control ligand. TB remains a significant world health concern, requiring the development of new drug candidates to address more drug-resistant variants. The target protein chosen was 3PTY. The molecular docking simulation showed that sulabiroin-A, sulabiroin-B, and broussoflavonol F docking scores are comparable to rifampicin, with the order of docking score from least favorable to more favorable is sulabiroin-B< sulabiroin-A< rifampicin< broussoflavonol F (-3.397, -3.449, -5.256, -5.961). Molecular dynamics simulations also demonstrated that sulabiroin-B exhibited stable interactions with the target protein, comparable to rifampicin, while sulabiroin-A and broussoflavonol F demonstrated increased fluctuation, suggesting possible instability. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) study verified that all three drugs possess advantageous pharmacokinetic characteristics, with broussoflavonol F exhibiting the most favorable safety and tolerability profile. According to these findings, sulabiroin-B is recognized as the most promising candidate for TB treatment owing to its enhanced stability in molecular dynamics simulations, although broussoflavonol F and sulabiroin-A exhibit intermediate promise. Additional experimental validation is advised to verify their therapeutic efficacy.
{"title":"Molecular Docking and Molecular Dynamics Study of Propolis Compounds of Sulabiroin-A, Sulabiroin-B, and Broussoflavonol F Toward Tuberculosis 3PTY Target Protein.","authors":"Jaka Fajar Fatriansyah, Agrin Febrian Pradana, Anggit Driasaditya, Aditya Asprilla Sinaga, Muhamad Sahlan, Siti Norasmah Surip","doi":"10.1155/jotm/6631193","DOIUrl":"https://doi.org/10.1155/jotm/6631193","url":null,"abstract":"<p><p>Molecular docking and molecular dynamics simulations were conducted to assess propolis compounds of sulabiroin-A, sulabiroin-B, and broussoflavonol F as tuberculosis (TB) inhibitors with rifampicin as the control ligand. TB remains a significant world health concern, requiring the development of new drug candidates to address more drug-resistant variants. The target protein chosen was 3PTY. The molecular docking simulation showed that sulabiroin-A, sulabiroin-B, and broussoflavonol F docking scores are comparable to rifampicin, with the order of docking score from least favorable to more favorable is sulabiroin-B< sulabiroin-A< rifampicin< broussoflavonol F (-3.397, -3.449, -5.256, -5.961). Molecular dynamics simulations also demonstrated that sulabiroin-B exhibited stable interactions with the target protein, comparable to rifampicin, while sulabiroin-A and broussoflavonol F demonstrated increased fluctuation, suggesting possible instability. Absorption, distribution, metabolism, excretion, and toxicity (ADMET) study verified that all three drugs possess advantageous pharmacokinetic characteristics, with broussoflavonol F exhibiting the most favorable safety and tolerability profile. According to these findings, sulabiroin-B is recognized as the most promising candidate for TB treatment owing to its enhanced stability in molecular dynamics simulations, although broussoflavonol F and sulabiroin-A exhibit intermediate promise. Additional experimental validation is advised to verify their therapeutic efficacy.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"6631193"},"PeriodicalIF":2.1,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12058314/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144006230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-23eCollection Date: 2025-01-01DOI: 10.1155/jotm/9926259
Chen Guoqing, Li Chunxiang, Cui Qian, Li Changcheng, Yang Pengfei, Yan Qingli, An Ran, Liu Wei, Li Feng, Lu Kuikui, Zhang Hongjun, Peng Haiyan
Objective: To investigate the infection status, species composition, and genetic diversity of Bartonella in local rodent populations in coastal mudflat wetland habitats in eastern Jiangsu Province of China. Methods: From March to June 2023, rodents were captured in mudflat wetlands of Dongtai and Tinghu Counties, Eastern China. Rodent species were identified, and nucleic acids were extracted from liver and spleen tissues. The mitochondrial cytochrome b (mt-cytb) gene was amplified by PCR, while Bartonella-specific citrate synthase (gltA) and 16S rRNA genes were amplified by semi-nested PCR. Phylogenetic and homology analyses were conducted to identify rodent and Bartonella species. Results: Among 29 captured rodents, 26 were Apodemus agrarius and 3 were Mus musculus. Phylogenetic analysis of the mt-cytb gene divided A. agrarius into 7 lineages, each linked to geographically diverse Bartonella populations. Six A. agrarius rodents tested positive for Bartonella, with a positivity rate of 20.69%. Phylogenetic analyses revealed three Bartonella species: B. fuyuanensis, B. taylorii, and one undetermined species. The infected Bartonella strains clustered into three evolutionary branches based on gltA and 16S rRNA genes. Conclusions: This study provides the first evidence of Bartonella infection among rodent populations in wetland habitats along China's eastern coast. The region harbors diverse rodent species, with a high Bartonella infection rate, and at least three species were identified, including a potential novel species.
{"title":"Prevalence, Species Characterization, and Genetic Diversity of <i>Bartonella</i> Infections in Rodents From Mudflat Wetlands Along the Eastern Coast of Jiangsu Province in China.","authors":"Chen Guoqing, Li Chunxiang, Cui Qian, Li Changcheng, Yang Pengfei, Yan Qingli, An Ran, Liu Wei, Li Feng, Lu Kuikui, Zhang Hongjun, Peng Haiyan","doi":"10.1155/jotm/9926259","DOIUrl":"https://doi.org/10.1155/jotm/9926259","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the infection status, species composition, and genetic diversity of <i>Bartonella</i> in local rodent populations in coastal mudflat wetland habitats in eastern Jiangsu Province of China. <b>Methods:</b> From March to June 2023, rodents were captured in mudflat wetlands of Dongtai and Tinghu Counties, Eastern China. Rodent species were identified, and nucleic acids were extracted from liver and spleen tissues. The mitochondrial cytochrome b (mt-<i>cytb</i>) gene was amplified by PCR, while <i>Bartonella</i>-specific citrate synthase (<i>gltA</i>) and 16S rRNA genes were amplified by semi-nested PCR. Phylogenetic and homology analyses were conducted to identify rodent and <i>Bartonella</i> species. <b>Results:</b> Among 29 captured rodents, 26 were <i>Apodemus agrarius</i> and 3 were <i>Mus musculus</i>. Phylogenetic analysis of the mt-<i>cytb</i> gene divided <i>A. agrarius</i> into 7 lineages, each linked to geographically diverse <i>Bartonella</i> populations. Six <i>A. agrarius</i> rodents tested positive for <i>Bartonella</i>, with a positivity rate of 20.69%. Phylogenetic analyses revealed three <i>Bartonella</i> species: <i>B. fuyuanensis</i>, <i>B. taylorii</i>, and one undetermined species. The infected <i>Bartonella</i> strains clustered into three evolutionary branches based on <i>gltA</i> and 16S rRNA genes. <b>Conclusions:</b> This study provides the first evidence of <i>Bartonella</i> infection among rodent populations in wetland habitats along China's eastern coast. The region harbors diverse rodent species, with a high <i>Bartonella</i> infection rate, and at least three species were identified, including a potential novel species.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"9926259"},"PeriodicalIF":2.1,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043437/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144021279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Currently, carbapenem-resistant Klebsiella pneumoniae (CR-KP) strains, particularly those producing New Delhi metallo-beta-lactamase (NDM), are increasingly recognized as a significant threat to global health. The present study aimed to conduct a genomic analysis of an NDM-1-producing CR-KP strain isolated from patients with coronavirus disease of 2019 (COVID-19) admitted to the intensive care unit (ICU). The K. pneumoniae isolate was obtained from the bronchoalveolar lavage fluid of a 68 year-old male patient hospitalized in the ICU with COVID-19 at Besat Hospital in Sanandaj, Iran. The minimum inhibitory concentrations (MICs) for 15 antibiotics were determined using the VITEK 2 system. Genomic analysis of the isolate was performed using whole genome sequencing. The CRKP-51 strain was identified as an extensively drug-resistant (XDR) strain, exhibiting resistance to all tested antibiotics except tigecycline (MIC = 2 μg/mL). The highest resistance values were recorded against sulfamethoxazole-trimethoprim (SXT), nitrofurantoin (NIT), and piperacillin-tazobactam (TZP), with MICs of ≥ 320, 256 μg/mL, and ≥ 128 μg/mL, respectively. Multilocus sequence typing revealed that CRKP-51 belonged to sequence type 15 (ST15). The IncHI1B replicon type associated with this strain harbored several resistance genes, including blaNDM-1, armA, msrE, mphE, BRP (MBL), blaOXA-1, aadA2, dfrA12, qnrB1, blaCTX-M-15, and cat1. High-risk K. pneumoniae clones, such as ST15, are increasingly associated with antimicrobial resistance and the emergence of XDR strains in ICUs. Additionally, the global dissemination of the NDM enzyme occurs through various plasmid replicon types. Therefore, monitoring local epidemiology is essential for the effectiveness of antimicrobial stewardship programs.
{"title":"Genomic Characterization of NDM-1 Harboring Extensively-Drug Resistance <i>Klebsiella pneumoniae</i> Isolate From ICU-Admitted Patient With COVID-19.","authors":"Abolfazl Rafati Zomorodi, Himen Salimizand, Niloufar Mohseni, Maryam Hafiz, Helia Nikoueian, Tahereh Gholamhosseini-Moghaddam, Fatemeh Aflakian","doi":"10.1155/jotm/6616950","DOIUrl":"https://doi.org/10.1155/jotm/6616950","url":null,"abstract":"<p><p>Currently, carbapenem-resistant <i>Klebsiella pneumoniae</i> (CR-KP) strains, particularly those producing New Delhi metallo-beta-lactamase (NDM), are increasingly recognized as a significant threat to global health. The present study aimed to conduct a genomic analysis of an NDM-1-producing CR-KP strain isolated from patients with coronavirus disease of 2019 (COVID-19) admitted to the intensive care unit (ICU). The <i>K. pneumoniae</i> isolate was obtained from the bronchoalveolar lavage fluid of a 68 year-old male patient hospitalized in the ICU with COVID-19 at Besat Hospital in Sanandaj, Iran. The minimum inhibitory concentrations (MICs) for 15 antibiotics were determined using the VITEK 2 system. Genomic analysis of the isolate was performed using whole genome sequencing. The CRKP-51 strain was identified as an extensively drug-resistant (XDR) strain, exhibiting resistance to all tested antibiotics except tigecycline (MIC = 2 μg/mL). The highest resistance values were recorded against sulfamethoxazole-trimethoprim (SXT), nitrofurantoin (NIT), and piperacillin-tazobactam (TZP), with MICs of ≥ 320, 256 μg/mL, and ≥ 128 μg/mL, respectively. Multilocus sequence typing revealed that CRKP-51 belonged to sequence type 15 (ST15). The IncHI1B replicon type associated with this strain harbored several resistance genes, including <i>bla</i> <sub><i>NDM</i>-1</sub> <i>, armA</i>, <i>msrE</i>, <i>mphE</i>, <i>BRP</i> (MBL), <i>bla</i> <sub><i>OXA</i>-1</sub>, <i>aadA</i>2, <i>dfrA</i>12, <i>qnrB</i>1, <i>bla</i> <sub><i>CTX</i>-<i>M</i>-15</sub>, and <i>cat</i>1. High-risk <i>K. pneumoniae</i> clones, such as ST15, are increasingly associated with antimicrobial resistance and the emergence of XDR strains in ICUs. Additionally, the global dissemination of the NDM enzyme occurs through various plasmid replicon types. Therefore, monitoring local epidemiology is essential for the effectiveness of antimicrobial stewardship programs.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"6616950"},"PeriodicalIF":2.1,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12011471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143975071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-14eCollection Date: 2025-01-01DOI: 10.1155/jotm/6340482
Amadou Barrow, Bakary Kinteh, Mansour Badjie, Amadou Kongira, Ayodeji Matthew Adebayo, Rex A Kuye, Edrisa Sanyang
Background: Malaria is one of the deadliest mosquito-borne diseases. Despite the demonstrated benefits of insecticide-treated nets (ITNs) usage in children under 5 years of age, nonuse is linked to higher mortality and morbidity rates. This study examined how child-, maternal-, household-, and community-level determinants influence ITN utilization among children under 5 in The Gambia for malaria prevention. It further elucidates how household environment, infrastructure, and drinking water sources mediate under-5 ITN utilization in The Gambia. Method: Secondary data analysis of The Gambia Demographic Health Survey (2019-2020) was conducted in this study. We used Chi-square test, linear model ANOVA, multivariable regression model, and mediation analysis to analyze the influence of child-, maternal-, household-, and community-level factors on under-5 ITN utilization in The Gambia. We computed crude and adjusted odds ratios (cOR and aOR, respectively) for potential confounders across groups, with statistical significance set at p < 0.05, and 95% confidence interval (CI). Results: The prevalence of ITN utilization among under-5 children was 63.4% (95% CI: 61.0%, 65.8%). This study identified several significant factors influencing under-5 ITN utilization in The Gambia, such as children's anemia status (aOR = 0.53, 95% CI [0.27, 0.97], p = 0.050), mother's literacy (aOR = 0.77, 95% CI [0.61, 0.96], p = 0.021), female household heads (aOR = 0.67, 95% CI [0.56, 0.81], p < 0.001), household wealth index (aOR = 0.55, 95% CI [0.42, 0.72], p < 0.001), and residence (aOR = 1.30, 95% CI [1.04, 1.62], p = 0.022). Ethnicity and region also influenced ITN utilization, with variations across different ethnic groups and regions (including Kerewan aOR = 2.29, 95% CI [1.54, 3.39], p < 0.001). Mediation analysis highlighted both the direct and indirect effects of household infrastructure and drinking water sources on ITN utilization, emphasizing the multifaceted nature of the factors influencing ITN use in this context. Conclusion: This study elucidates the complex factors influencing ITN utilization among children under 5 years of age in The Gambia. The nuanced understanding of individual-, household-, and community-level factors offers a robust foundation for targeted strategies for malaria prevention, with far-reaching implications for public health policy and practice.
背景:疟疾是最致命的蚊媒疾病之一。尽管在5岁以下儿童中使用经杀虫剂处理的蚊帐有明显的好处,但不使用蚊帐与较高的死亡率和发病率有关。本研究调查了儿童、母亲、家庭和社区层面的决定因素如何影响冈比亚5岁以下儿童为预防疟疾而使用ITN。它进一步阐明了家庭环境、基础设施和饮用水源如何影响冈比亚5岁以下儿童对杀虫剂的利用。方法:本研究采用《冈比亚人口健康调查(2019-2020)》的二次数据分析。我们采用卡方检验、线性模型方差分析、多变量回归模型和中介分析来分析儿童、母亲、家庭和社区层面因素对冈比亚5岁以下ITN使用的影响。我们计算各组潜在混杂因素的粗比值比和校正比值比(分别为cOR和aOR),统计学显著性设置为p < 0.05, 95%可信区间(CI)。结果:5岁以下儿童ITN使用率为63.4% (95% CI: 61.0%, 65.8%)。本研究确定了影响冈比亚5岁以下ITN使用率的几个重要因素,如儿童贫血状况(aOR = 0.53, 95% CI [0.27, 0.97], p = 0.050)、母亲的识字程度(aOR = 0.77, 95% CI [0.61, 0.96], p = 0.021)、女性户主(aOR = 0.67, 95% CI [0.56, 0.81], p < 0.001)、家庭财富指数(aOR = 0.55, 95% CI [0.42, 0.72], p < 0.001)和住所(aOR = 1.30, 95% CI [1.04, 1.62], p = 0.022)。民族和地区也影响ITN的使用,不同民族和地区之间存在差异(包括Kerewan aOR = 2.29, 95% CI [1.54, 3.39], p < 0.001)。调解分析强调了家庭基础设施和饮用水源对间驱蚊帐利用的直接和间接影响,强调了在这种情况下影响间驱蚊帐使用的因素的多面性。结论:本研究阐明了影响冈比亚5岁以下儿童ITN使用的复杂因素。对个人、家庭和社区层面因素的细致理解为有针对性的疟疾预防战略提供了坚实的基础,对公共卫生政策和实践具有深远的影响。
{"title":"Determinants of Insecticide-Treated Net Utilization for Malaria Prevention Among Under-Five Children in The Gambia: Evidence From National Survey.","authors":"Amadou Barrow, Bakary Kinteh, Mansour Badjie, Amadou Kongira, Ayodeji Matthew Adebayo, Rex A Kuye, Edrisa Sanyang","doi":"10.1155/jotm/6340482","DOIUrl":"https://doi.org/10.1155/jotm/6340482","url":null,"abstract":"<p><p><b>Background:</b> Malaria is one of the deadliest mosquito-borne diseases. Despite the demonstrated benefits of insecticide-treated nets (ITNs) usage in children under 5 years of age, nonuse is linked to higher mortality and morbidity rates. This study examined how child-, maternal-, household-, and community-level determinants influence ITN utilization among children under 5 in The Gambia for malaria prevention. It further elucidates how household environment, infrastructure, and drinking water sources mediate under-5 ITN utilization in The Gambia. <b>Method:</b> Secondary data analysis of The Gambia Demographic Health Survey (2019-2020) was conducted in this study. We used Chi-square test, linear model ANOVA, multivariable regression model, and mediation analysis to analyze the influence of child-, maternal-, household-, and community-level factors on under-5 ITN utilization in The Gambia. We computed crude and adjusted odds ratios (cOR and aOR, respectively) for potential confounders across groups, with statistical significance set at <i>p</i> < 0.05, and 95% confidence interval (CI). <b>Results:</b> The prevalence of ITN utilization among under-5 children was 63.4% (95% CI: 61.0%, 65.8%). This study identified several significant factors influencing under-5 ITN utilization in The Gambia, such as children's anemia status (aOR = 0.53, 95% CI [0.27, 0.97], <i>p</i> = 0.050), mother's literacy (aOR = 0.77, 95% CI [0.61, 0.96], <i>p</i> = 0.021), female household heads (aOR = 0.67, 95% CI [0.56, 0.81], <i>p</i> < 0.001), household wealth index (aOR = 0.55, 95% CI [0.42, 0.72], <i>p</i> < 0.001), and residence (aOR = 1.30, 95% CI [1.04, 1.62], <i>p</i> = 0.022). Ethnicity and region also influenced ITN utilization, with variations across different ethnic groups and regions (including Kerewan aOR = 2.29, 95% CI [1.54, 3.39], <i>p</i> < 0.001). Mediation analysis highlighted both the direct and indirect effects of household infrastructure and drinking water sources on ITN utilization, emphasizing the multifaceted nature of the factors influencing ITN use in this context. <b>Conclusion:</b> This study elucidates the complex factors influencing ITN utilization among children under 5 years of age in The Gambia. The nuanced understanding of individual-, household-, and community-level factors offers a robust foundation for targeted strategies for malaria prevention, with far-reaching implications for public health policy and practice.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"6340482"},"PeriodicalIF":2.1,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12011457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: In the last two decades, Human immune deficiency virus has been a major health concern in sub-Saharan Africa particularly in Ethiopia. The objective of this study was to identify determinants associated with CD4 cell count and disclosure status among first-line antiretroviral therapy patients treated at Felege Hiwot Comprehensive Specialized Hospital, Ethiopia. Methods: This retrospective study was conducted at Felege Hiwot Comprehensive Specialized Hospital. Data analysis was conducted using Statistical System Analysis (SAS) software Version 9.4. In this study, quasi-Poisson mixed-effects model for CD4 cell count, a binary logistic regression model for disclosure status, and joint modeling were used. Result: Out of 300 adult participants, around 76% of the patients were discloses their disease status to their family members. The correlation between CD4 cell count and disclosure was positive (0.4607). The current study indicates that among the predictor variables, noneducators (β = -0.6185, p-value < 0.01), primary educators (β = -0.3687, p-value < 0.01), employed patients (β = 0.3888, p-value < 0.01), adherent patients (β = 0.2274, p-value < 0.01), and patients who did not had social support (β = -0.1148, p-value = 0.030) have a significant effect for CD4 cell count. Similarly, noneducators (AOR = 0.000145, p-value < 0.01), primary educators (AOR = 0.004413, p-value < 0.01), employed patients (AOR = 3.4562, p-value = 0.021), adherent patients (AOR = 1.564, p-value < 0.01), and patients who did not had social support (AOR = 0.075, p-value = 0.0078) had a significant effect for disclosure status. Conclusion: This study concluded that patients who had disclosed their disease status to near relatives or families have a positive correlation with CD4 cell count through time. This study also concluded that significant determinants affected both the variables of interest were educational level, occupation, adherence, and social support. Health professionals should give more attention to these important determinants to create good status of patients. In addition, health staff should conduct health-related studies for individuals to understand better ART follow-up. Patients should be adhere to their prescribed HIV medication properly on time and disclose their disease status without fearing stigma and discrimination to the community; this may help to increase their CD4 cell count. The family members should give social support to the infected patients, and the government should work on education; this may help to improve their CD4 cell count and increase the prevalence of disclosure of the disease status. The authors also recommended that further studies of this nature include other important variables that are not included in this study such as income of the patients and many other covariates.
{"title":"Determinants Associated With CD4 Cell Count and Disclosure Status Among First-Line Antiretroviral Therapy Patients Treated at Felege Hiwot Comprehensive Specialized Hospital, Ethiopia.","authors":"Abdela Assefa Bekele, Awoke Seyoum Tegegne, Nurye Seid Muhie","doi":"10.1155/jotm/5989447","DOIUrl":"https://doi.org/10.1155/jotm/5989447","url":null,"abstract":"<p><p><b>Background:</b> In the last two decades, Human immune deficiency virus has been a major health concern in sub-Saharan Africa particularly in Ethiopia. The objective of this study was to identify determinants associated with CD4 cell count and disclosure status among first-line antiretroviral therapy patients treated at Felege Hiwot Comprehensive Specialized Hospital, Ethiopia. <b>Methods:</b> This retrospective study was conducted at Felege Hiwot Comprehensive Specialized Hospital. Data analysis was conducted using Statistical System Analysis (SAS) software Version 9.4. In this study, quasi-Poisson mixed-effects model for CD4 cell count, a binary logistic regression model for disclosure status, and joint modeling were used. <b>Result:</b> Out of 300 adult participants, around 76% of the patients were discloses their disease status to their family members. The correlation between CD4 cell count and disclosure was positive (0.4607). The current study indicates that among the predictor variables, noneducators (<i>β</i> = -0.6185, <i>p</i>-value < 0.01), primary educators (<i>β</i> = -0.3687, <i>p</i>-value < 0.01), employed patients (<i>β</i> = 0.3888, <i>p</i>-value < 0.01), adherent patients (<i>β</i> = 0.2274, <i>p</i>-value < 0.01), and patients who did not had social support (<i>β</i> = -0.1148, <i>p</i>-value = 0.030) have a significant effect for CD4 cell count. Similarly, noneducators (AOR = 0.000145, <i>p</i>-value < 0.01), primary educators (AOR = 0.004413, <i>p</i>-value < 0.01), employed patients (AOR = 3.4562, <i>p</i>-value = 0.021), adherent patients (AOR = 1.564, <i>p</i>-value < 0.01), and patients who did not had social support (AOR = 0.075, <i>p</i>-value = 0.0078) had a significant effect for disclosure status. <b>Conclusion:</b> This study concluded that patients who had disclosed their disease status to near relatives or families have a positive correlation with CD4 cell count through time. This study also concluded that significant determinants affected both the variables of interest were educational level, occupation, adherence, and social support. Health professionals should give more attention to these important determinants to create good status of patients. In addition, health staff should conduct health-related studies for individuals to understand better ART follow-up. Patients should be adhere to their prescribed HIV medication properly on time and disclose their disease status without fearing stigma and discrimination to the community; this may help to increase their CD4 cell count. The family members should give social support to the infected patients, and the government should work on education; this may help to improve their CD4 cell count and increase the prevalence of disclosure of the disease status. The authors also recommended that further studies of this nature include other important variables that are not included in this study such as income of the patients and many other covariates.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"5989447"},"PeriodicalIF":2.1,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12009679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144002225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vitamin D is an important modulator of host immune response during immunity development in context to several diseases in children. This study included 280 pediatric dengue cases, which were further stratified as dengue fever (DF), dengue with warning signs (DWS), and severe dengue (SD), wherein naturally circulating vitamin D metabolite, 25(OH)D was assessed, followed by statistical analysis for elucidating the role of serum 25(OH)D in dengue severity. qRT-PCR based serotyping showed that dengue virus (DENV)-2 was the major circulating DENV serotype in the patients. Among DENV cases, 92 (32.86%), 108 (38.57%), and 80 (28.57%) were diagnosed with DF, DWS, and SD, respectively. Among SD patients, serum 25(OH)D deficiency and insufficiency were observed in 37 (46.25%) and 43 (53.75%) patients, respectively, and found to be significantly associated with SD (p < 0.05) in comparison to DF and DWS. Serum 25(OH)D sufficiency had a protective effect against dengue severity and could be a determinant for DENV outcome in children.
{"title":"Vitamin D Deficiency is Associated With Dengue Severity in Pediatric Cases, Eastern India.","authors":"Sagnika Samal, Manoj Kumar Dash, Chinmay Kumar Behera, Gyanraj Singh, Mahesh Chandra Sahu, Biswadeep Das","doi":"10.1155/jotm/2863024","DOIUrl":"https://doi.org/10.1155/jotm/2863024","url":null,"abstract":"<p><p>Vitamin D is an important modulator of host immune response during immunity development in context to several diseases in children. This study included 280 pediatric dengue cases, which were further stratified as dengue fever (DF), dengue with warning signs (DWS), and severe dengue (SD), wherein naturally circulating vitamin D metabolite, 25(OH)D was assessed, followed by statistical analysis for elucidating the role of serum 25(OH)D in dengue severity. qRT-PCR based serotyping showed that dengue virus (DENV)-2 was the major circulating DENV serotype in the patients. Among DENV cases, 92 (32.86%), 108 (38.57%), and 80 (28.57%) were diagnosed with DF, DWS, and SD, respectively. Among SD patients, serum 25(OH)D deficiency and insufficiency were observed in 37 (46.25%) and 43 (53.75%) patients, respectively, and found to be significantly associated with SD (<i>p</i> < 0.05) in comparison to DF and DWS. Serum 25(OH)D sufficiency had a protective effect against dengue severity and could be a determinant for DENV outcome in children.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"2863024"},"PeriodicalIF":2.1,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11991798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143989803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hepatitis B virus (HBV) infection remains a critical global health issue, particularly in high-burden regions with substantial global morbidity and mortality. Despite the efficacy of the hepatitis B vaccine in inducing immunity, a subset of vaccinated individuals fails to achieve adequate immunity. This study investigated the factors influencing immunological response to the hepatitis B vaccine among Nigerian adults. A cohort study was conducted at Usmanu Danfodiyo University Teaching Hospital, Sokoto, involving 307 participants aged 19-60 who had not previously received the hepatitis B vaccine. Data were collected using structured questionnaires assessing demographic characteristics, medical history, and lifestyle factors. Participants received GeneVac-B, a recombinant hepatitis B vaccine, and 0-, 1-, and 2-month schedule anti-HB levels were measured post-vaccination using a commercial enzyme-linked immunosorbent assay (ELISA) kit (AccuDiag ELISA, Diagnostic Automation/Cortez Diagnostics, Inc., USA) to classify vaccine response. The association between demographic and lifestyle factors and vaccine response was analyzed using IBM SPSS Statistics (Version 25). Of the 307 participants, 209 received the first vaccine dose, and 192 completed all three doses. Anti-HB quantification revealed that 94.3% of the participants achieved protective immunity (≥ 10 IU/L), while 5.7% were classified as nonresponders (< 10 IU/L). Statistical analysis indicated significant differences in the immune response based on gender (p = 0.031), with females exhibiting higher mean anti-HB levels than males. Negative correlations were observed between age and vaccine response (ρ = -0.296, p < 0.01) and between body mass index (BMI) and response, although the latter was not statistically significant (ρ = -0.131, p = 0.071). Prior tuberculosis, malaria, measles, smoking, and alcohol use showed no significant impact on the immune response, although recurrent malaria, measles, and smoking were associated with slightly lower mean antibody levels. The study indicates gender and age significantly influence hepatitis B vaccine response, with females and younger individuals demonstrating stronger immunity.
{"title":"Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study.","authors":"Shuaibu Abdullahi Hudu, Abdulgafar Olayiwola Jimoh, Sa'adatu Haruna Shinkafi, Albashir Tahir, Ahmed Subeh Alshrari, Muhammad Tukur Umar, Abdulmajeed Yunusa, Nura Bello, Nura Abubakar","doi":"10.1155/jotm/3879562","DOIUrl":"10.1155/jotm/3879562","url":null,"abstract":"<p><p>Hepatitis B virus (HBV) infection remains a critical global health issue, particularly in high-burden regions with substantial global morbidity and mortality. Despite the efficacy of the hepatitis B vaccine in inducing immunity, a subset of vaccinated individuals fails to achieve adequate immunity. This study investigated the factors influencing immunological response to the hepatitis B vaccine among Nigerian adults. A cohort study was conducted at Usmanu Danfodiyo University Teaching Hospital, Sokoto, involving 307 participants aged 19-60 who had not previously received the hepatitis B vaccine. Data were collected using structured questionnaires assessing demographic characteristics, medical history, and lifestyle factors. Participants received GeneVac-B, a recombinant hepatitis B vaccine, and 0-, 1-, and 2-month schedule anti-HB levels were measured post-vaccination using a commercial enzyme-linked immunosorbent assay (ELISA) kit (AccuDiag ELISA, Diagnostic Automation/Cortez Diagnostics, Inc., USA) to classify vaccine response. The association between demographic and lifestyle factors and vaccine response was analyzed using IBM SPSS Statistics (Version 25). Of the 307 participants, 209 received the first vaccine dose, and 192 completed all three doses. Anti-HB quantification revealed that 94.3% of the participants achieved protective immunity (≥ 10 IU/L), while 5.7% were classified as nonresponders (< 10 IU/L). Statistical analysis indicated significant differences in the immune response based on gender (<i>p</i> = 0.031), with females exhibiting higher mean anti-HB levels than males. Negative correlations were observed between age and vaccine response (<i>ρ</i> = -0.296, <i>p</i> < 0.01) and between body mass index (BMI) and response, although the latter was not statistically significant (<i>ρ</i> = -0.131, <i>p</i> = 0.071). Prior tuberculosis, malaria, measles, smoking, and alcohol use showed no significant impact on the immune response, although recurrent malaria, measles, and smoking were associated with slightly lower mean antibody levels. The study indicates gender and age significantly influence hepatitis B vaccine response, with females and younger individuals demonstrating stronger immunity.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"3879562"},"PeriodicalIF":2.1,"publicationDate":"2025-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11968161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143780400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-16eCollection Date: 2025-01-01DOI: 10.1155/jotm/6165665
Tuan Huu Ngoc Nguyen, Huy Quang Nguyen, Ngan Thi Thu Le, Han To Ngoc Nguyen, Hung Cao Dinh, Tam Ngoc Nguyen, Ha Minh Nguyen
Introduction:A. baumannii and P. aeruginosa belong to the multidrug-resistant Gram-negative bacteria group, posing significant challenges in treatment. Colistin is considered the last-line antibiotic for treating this bacterium. It is essential to determine the minimum inhibitory concentration (MIC) to adjust the appropriate dosage. Method: A cross-sectional descriptive study using data from January 2020 to December 2024 was conducted. Results: The infections caused by A. baumannii and P. aeruginosa showed an increasing trend over the years, accounting for 17.4% and 9.6% of common multidrug-resistant Gram-negative bacteria, respectively. A. baumannii exhibited higher resistance rates than P. aeruginosa with multiple tested antibiotics. Although no Colistin-resistant strains were observed for either bacterium of interest during the observation period, both bacteria of interest showed a statistically significant change during the survey period (p < 0.05). In addition, the MIC value of ≤ 0.75 μg/mL was the most prevalent over 80% from 2020 to 2021, but its percentage declined strongly by 60%-65% in the next 3 years (p < 0.0001). Meanwhile, the MIC value of 1.0 μg/mL became the most common over 70% with a statistically significant difference (p < 0.0001). Regarding the MIC value based on infection types, the MIC value for P. aeruginosa causing septicemia was considerably concentrated at 1.0 μg/mL at 84.6%, while its percentage was lower in A. baumannii at 37.9% (p < 0.0001). Looking into MIC values based on carbapenem-resistant proportions, the MIC values from 1.0 to 2.0 μg/mL were higher in imipenem-resistant strains of both bacteria of interest compared with nonresistant strains (p < 0.0001). This difference was also observed in meropenem-resistant A. baumannii but was not demonstrated in P. aeruginosa. Conclusions: Although no colistin-resistant strains were observed, A. baumannii and P. aeruginosa showed statistically significant changes in the most prevalent colistin MIC values, which have been approaching the resistance threshold over the years. It is essential to implement control measures of colistin usage before bacteria become completely resistant.
{"title":"Trends of Colistin MIC Among <i>Acinetobacter Baumannii</i> and <i>Pseudomonas aeruginosa</i> at a First-Class Hospital in Vietnam.","authors":"Tuan Huu Ngoc Nguyen, Huy Quang Nguyen, Ngan Thi Thu Le, Han To Ngoc Nguyen, Hung Cao Dinh, Tam Ngoc Nguyen, Ha Minh Nguyen","doi":"10.1155/jotm/6165665","DOIUrl":"10.1155/jotm/6165665","url":null,"abstract":"<p><p><b>Introduction:</b> <i>A. baumannii</i> and <i>P. aeruginosa</i> belong to the multidrug-resistant Gram-negative bacteria group, posing significant challenges in treatment. Colistin is considered the last-line antibiotic for treating this bacterium. It is essential to determine the minimum inhibitory concentration (MIC) to adjust the appropriate dosage. <b>Method:</b> A cross-sectional descriptive study using data from January 2020 to December 2024 was conducted. <b>Results:</b> The infections caused by <i>A. baumannii</i> and <i>P. aeruginosa</i> showed an increasing trend over the years, accounting for 17.4% and 9.6% of common multidrug-resistant Gram-negative bacteria, respectively. <i>A. baumannii</i> exhibited higher resistance rates than <i>P. aeruginosa</i> with multiple tested antibiotics. Although no Colistin-resistant strains were observed for either bacterium of interest during the observation period, both bacteria of interest showed a statistically significant change during the survey period (<i>p</i> < 0.05). In addition, the MIC value of ≤ 0.75 μg/mL was the most prevalent over 80% from 2020 to 2021, but its percentage declined strongly by 60%-65% in the next 3 years (<i>p</i> < 0.0001). Meanwhile, the MIC value of 1.0 μg/mL became the most common over 70% with a statistically significant difference (<i>p</i> < 0.0001). Regarding the MIC value based on infection types, the MIC value for <i>P. aeruginosa</i> causing septicemia was considerably concentrated at 1.0 μg/mL at 84.6%, while its percentage was lower in <i>A. baumannii</i> at 37.9% (<i>p</i> < 0.0001). Looking into MIC values based on carbapenem-resistant proportions, the MIC values from 1.0 to 2.0 μg/mL were higher in imipenem-resistant strains of both bacteria of interest compared with nonresistant strains (<i>p</i> < 0.0001). This difference was also observed in meropenem-resistant <i>A. baumannii</i> but was not demonstrated in <i>P. aeruginosa</i>. <b>Conclusions:</b> Although no colistin-resistant strains were observed, <i>A. baumannii</i> and <i>P. aeruginosa</i> showed statistically significant changes in the most prevalent colistin MIC values, which have been approaching the resistance threshold over the years. It is essential to implement control measures of colistin usage before bacteria become completely resistant.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"6165665"},"PeriodicalIF":2.1,"publicationDate":"2025-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11930383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143692528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objectives: Neglected tropical diseases (NTDs), such as leprosy, significantly impact mental health and overall well-being. This study aims to evaluate the effectiveness and acceptability of a mental health intervention targeting individuals affected by leprosy in Ethiopia. The intervention utilizes the Traumatic Stress Relief (TSR) program to target symptoms of posttraumatic stress disorder (PTSD), anxiety, and depression, and to improve overall mental health. Methods: This exploratory randomized controlled trial (RCT) will recruit participants with lived experiences of leprosy. Participants will receive four group sessions of a low-intensity TSR intervention. The intervention will be administered by a pair of trained facilitators, including one mental health practitioner and one community member with lived experience of leprosy. Data will be collected through self-report questionnaires to assess changes in PTSD symptoms, anxiety, and depression. In addition, interviews will provide further insights into participants' experiences and the acceptability of the intervention. Discussion: This exploratory trial will provide insights into the feasibility of mental health interventions for individuals affected by leprosy. The findings will inform the design of future trials to evaluate the effectiveness of such programs on a larger scale and in more diverse contexts. Trial Registration: The UK's Clinical Study Registry: ISRCTN868254411.
{"title":"Protocol for an Exploratory RCT of the Traumatic Stress Relief Intervention With Persons With Lived Experience of Leprosy in Addis Ababa, Ethiopia.","authors":"Safa Kemal Kaptan, Marekegn Habtamu, Solomon Getahun, Beletshachew Tadesse, Ayse Akan, Adeline Pupat, Cécile Bizouerne, Nusrat Husain","doi":"10.1155/jotm/1307578","DOIUrl":"10.1155/jotm/1307578","url":null,"abstract":"<p><p><b>Objectives:</b> Neglected tropical diseases (NTDs), such as leprosy, significantly impact mental health and overall well-being. This study aims to evaluate the effectiveness and acceptability of a mental health intervention targeting individuals affected by leprosy in Ethiopia. The intervention utilizes the Traumatic Stress Relief (TSR) program to target symptoms of posttraumatic stress disorder (PTSD), anxiety, and depression, and to improve overall mental health. <b>Methods:</b> This exploratory randomized controlled trial (RCT) will recruit participants with lived experiences of leprosy. Participants will receive four group sessions of a low-intensity TSR intervention. The intervention will be administered by a pair of trained facilitators, including one mental health practitioner and one community member with lived experience of leprosy. Data will be collected through self-report questionnaires to assess changes in PTSD symptoms, anxiety, and depression. In addition, interviews will provide further insights into participants' experiences and the acceptability of the intervention. <b>Discussion:</b> This exploratory trial will provide insights into the feasibility of mental health interventions for individuals affected by leprosy. The findings will inform the design of future trials to evaluate the effectiveness of such programs on a larger scale and in more diverse contexts. <b>Trial Registration:</b> The UK's Clinical Study Registry: ISRCTN868254411.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"1307578"},"PeriodicalIF":2.5,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11925633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143670230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-04eCollection Date: 2025-01-01DOI: 10.1155/jotm/2286964
Fatimazahra El Fatoiki, Yousra Habibi, Anas Saddik, Fouzia Hali, Soumya Chiheb
Introduction: Herpes zoster is a viral dermatosis that occurs after reactivation of the varicella-zoster virus (VZV). The aim of this study is to illustrate the epidemiological and clinical aspects, as well as the complications, of herpes zoster in children. Materials and Methods: This is a descriptive, prospective study of a series of 25 children followed for herpes zoster over a 3 year period in the dermatology department of CHU Ibn Rochd in Casablanca. Results: There were 16 boys and 9 girls, with a mean age of 8.05 years. None of the patients had been vaccinated against varicella. Nine patients were immunocompromised. All patients were treated with antivirals, analgesics, antiseptics, and antibiotics (for seven infected patients). All patients had a favorable outcome with no sequelae. Discussion: VZV belongs to the Herpesviridae family, an enveloped virus with a DNA genome. It has a particular affinity for the skin, nervous system, and lungs. Shingles is a rare disease in children, which typically follows a favorable course without sequelae. In children with shingles, if the history and physical examination are normal, laboratory testing for occult immunodeficiency or malignancy is not necessary. The diagnosis is primarily clinical. Except for ophthalmic forms, complicated cases, and immunocompromised patients, no specific treatment is required. In immunocompromised children, the infection is usually severe and disseminated, leading to high morbidity and mortality, and requires specific intravenous antiviral treatment. Conclusion: Herpes zoster is a rare condition in children, typically evolving without sequelae.
简介:带状疱疹是一种病毒性皮肤病,发生在水痘带状疱疹病毒(VZV)再激活后。本研究的目的是说明流行病学和临床方面,以及并发症,带状疱疹在儿童。材料和方法:这是一项描述性的前瞻性研究,对卡萨布兰卡CHU Ibn Rochd皮肤科的25名带状疱疹儿童进行了为期3年的随访。结果:男16例,女9例,平均年龄8.05岁。这些病人都没有接种过水痘疫苗。9例患者免疫功能低下。所有患者均接受抗病毒药物、镇痛药、防腐剂和抗生素治疗(7例感染患者)。所有患者预后良好,无后遗症。讨论:VZV属于疱疹病毒科,是一种具有DNA基因组的包膜病毒。它对皮肤、神经系统和肺部有特殊的亲和力。带状疱疹是一种罕见的儿童疾病,通常病程良好,无后遗症。对于带状疱疹儿童,如果病史和体格检查正常,则不需要进行隐匿性免疫缺陷或恶性肿瘤的实验室检查。诊断主要是临床诊断。除眼科形式、复杂病例和免疫功能低下患者外,不需要特异性治疗。在免疫功能低下的儿童中,感染通常是严重的和播散性的,导致高发病率和死亡率,需要特异性静脉注射抗病毒治疗。结论:带状疱疹是一种罕见的儿童疾病,通常没有后遗症。
{"title":"Herpes Zoster: A Rare Dermatosis in Childhood (About 25 Cases).","authors":"Fatimazahra El Fatoiki, Yousra Habibi, Anas Saddik, Fouzia Hali, Soumya Chiheb","doi":"10.1155/jotm/2286964","DOIUrl":"https://doi.org/10.1155/jotm/2286964","url":null,"abstract":"<p><p><b>Introduction:</b> Herpes zoster is a viral dermatosis that occurs after reactivation of the varicella-zoster virus (VZV). The aim of this study is to illustrate the epidemiological and clinical aspects, as well as the complications, of herpes zoster in children. <b>Materials and Methods:</b> This is a descriptive, prospective study of a series of 25 children followed for herpes zoster over a 3 year period in the dermatology department of CHU Ibn Rochd in Casablanca. <b>Results:</b> There were 16 boys and 9 girls, with a mean age of 8.05 years. None of the patients had been vaccinated against varicella. Nine patients were immunocompromised. All patients were treated with antivirals, analgesics, antiseptics, and antibiotics (for seven infected patients). All patients had a favorable outcome with no sequelae. <b>Discussion:</b> VZV belongs to the Herpesviridae family, an enveloped virus with a DNA genome. It has a particular affinity for the skin, nervous system, and lungs. Shingles is a rare disease in children, which typically follows a favorable course without sequelae. In children with shingles, if the history and physical examination are normal, laboratory testing for occult immunodeficiency or malignancy is not necessary. The diagnosis is primarily clinical. Except for ophthalmic forms, complicated cases, and immunocompromised patients, no specific treatment is required. In immunocompromised children, the infection is usually severe and disseminated, leading to high morbidity and mortality, and requires specific intravenous antiviral treatment. <b>Conclusion:</b> Herpes zoster is a rare condition in children, typically evolving without sequelae.</p>","PeriodicalId":17527,"journal":{"name":"Journal of Tropical Medicine","volume":"2025 ","pages":"2286964"},"PeriodicalIF":2.1,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11987053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144010821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}